Roche Launches HTLV-I/II Assay in Global Markets
New test for the Roche serology assay portfolio helps specialists to identify HTLV-I/II infection in donated blood and diagnostic samples.
Read MorePosted by Steve Halasey | Jul 28, 2015 | Infectious Diseases |
New test for the Roche serology assay portfolio helps specialists to identify HTLV-I/II infection in donated blood and diagnostic samples.
Read MorePosted by Elaine Sanchez Wilson | May 8, 2015 | Cancer, Colorectal, Molecular Diagnostics |
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read MorePosted by Steve Halasey | Jan 15, 2015 | Cancer, Leukemia, Melanoma, Molecular Diagnostics, Research, Unknown Origin & Other Cancer Types |
After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read MorePosted by Steve Halasey | Jan 12, 2015 | Research |
Researchers at Ohio State University have identified patterns of RNA molecules that predict response to therapy and overall survival among older acute myeloid leukemia patients.
Read MorePosted by Steve Halasey | Aug 25, 2014 | Cancer |
CAP ’14, the College of American Pathologists annual meeting, September 7–10, will feature advances in molecular medicine, genetic testing, and laboratory technologies.
Read More